1. Yang, Jin Won, Kim, Hyo Seon, Choi, Yong-Won, Kim, Young-Mi, Kang, Keon Wook. 2017. Therapeutic application of GPR119 ligands in metabolic disorders. In Diabetes, obesity & metabolism, 20, 257-269. doi:10.1111/dom.13062. https://pubmed.ncbi.nlm.nih.gov/28722242/
2. Igarashi, Miki, Hayakawa, Tetsuhiko, Tanabe, Haruka, Nishida, Akari, Kimura, Ikuo. 2022. Intestinal GPR119 activation by microbiota-derived metabolites impacts feeding behavior and energy metabolism. In Molecular metabolism, 67, 101649. doi:10.1016/j.molmet.2022.101649. https://pubmed.ncbi.nlm.nih.gov/36462626/
3. Chepurny, Oleg G, Bertinetti, Daniela, Diskar, Mandy, Herberg, Friedrich W, Holz, George G. 2013. Stimulation of proglucagon gene expression by human GPR119 in enteroendocrine L-cell line GLUTag. In Molecular endocrinology (Baltimore, Md.), 27, 1267-82. doi:10.1210/me.2013-1029. https://pubmed.ncbi.nlm.nih.gov/23798572/
4. Kamaura, Masahiro, Kubo, Osamu, Sugimoto, Hiromichi, Murata, Toshiki, Sato, Kenjiro. 2021. Discovery of a novel series of indolinylpyrimidine-based GPR119 agonists: Elimination of ether-a-go-go-related gene liability using a hydrogen bond acceptor-focused approach. In Bioorganic & medicinal chemistry, 34, 116034. doi:10.1016/j.bmc.2021.116034. https://pubmed.ncbi.nlm.nih.gov/33548803/
5. Markovics, Arnold, Angyal, Ágnes, Tóth, Kinga Fanni, Bíró, Tamás, Oláh, Attila. 2020. GPR119 Is a Potent Regulator of Human Sebocyte Biology. In The Journal of investigative dermatology, 140, 1909-1918.e8. doi:10.1016/j.jid.2020.02.011. https://pubmed.ncbi.nlm.nih.gov/32142797/
6. Panaro, Brandon L, Flock, Grace B, Campbell, Jonathan E, Cao, Xiemin, Drucker, Daniel J. 2017. β-Cell Inactivation of Gpr119 Unmasks Incretin Dependence of GPR119-Mediated Glucoregulation. In Diabetes, 66, 1626-1635. doi:10.2337/db17-0017. https://pubmed.ncbi.nlm.nih.gov/28254842/
7. Yang, Jin Won, Kim, Hyo Seon, Im, Ji Hye, Kim, Sang Kyum, Kang, Keon Wook. 2015. GPR119: a promising target for nonalcoholic fatty liver disease. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 30, 324-35. doi:10.1096/fj.15-273771. https://pubmed.ncbi.nlm.nih.gov/26399788/